La Neumonía en la era de la Precisión: Integrando la Evidencia 2025 con la Realidad Epidemiológica Colombiana
Authors:
- Héctor Andrés Guerra RomeroHRHéctor Andrés Guerra Romero
- Said Antonio Durante FurnielesSFSaid Antonio Durante Furnieles
- Juan Antonio Méndez CamargoJCJuan Antonio Méndez Camargo
- Andrés Arturo Vivas ChaconACAndrés Arturo Vivas Chacon
- Juan Pablo Acosta D'LUyzJDJuan Pablo Acosta D'LUyz
- Angie Tatiana Valero PalominoAPAngie Tatiana Valero Palomino
- María José Juvinao MoralesMMMaría José Juvinao Morales
Open Access
- 16 January 2026
- journal article
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 5 (1) , 997-1003
Abstract
Introduction: Community-acquired pneumonia (CAP) is no longer a static clinical entity but rather a dynamic syndrome of systemic dysregulation. The publication of the 2025 American Thoracic Society (ATS) guidelines and the recommendations of the Colombian Association of Infectious Diseases (ACIN) demand a profound update of clinical practice. Development: Through a narrative review of the 2024–2025 literature, this article proposes a paradigm shift from blind empirical treatment to phenotype-driven therapy guided by local ecology. Colombian epidemiology is analyzed, highlighting macrolide resistance in Streptococcus pneumoniae (>30%), which mandates abandonment of monotherapy. Risk stratification is discussed, demonstrating the superiority of the SMART-COP score over CURB-65 in predicting the need for intensive respiratory or vasopressor support. From a therapeutic standpoint, the use of hydrocortisone in severe CAP is validated (CAPE COD trial), and ampicillin/sulbactam is positioned as the cornerstone of local inpatient management, with emphasis on safety protocols to prevent cefepime-associated neurotoxicity. Conclusion: Precision medicine in pneumonia is not a luxury but a safety standard. Adapting global evidence to local microbiology and using advanced predictive scores are life-saving interventions.Keywords
This publication has 14 references indexed in Scilit:
- Hydrocortisone in Severe Community-Acquired PneumoniaNew England Journal of Medicine, 2023
- The evolving burden of viruses in pneumoniaCurrent Opinion in Infectious Diseases, 2019
- Aspiration PneumoniaNew England Journal of Medicine, 2019
- A Randomized Clinical Trial Comparing the Effects of Antitussive Agents on Respiratory Center Output in Patients With Chronic CoughChest, 2017
- Efficacy and Tolerability of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in Bronchiectasis (Non-CF Etiology): Results From the Phase III RESPIRE 1 StudyChest, 2016
- Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory ResponseJAMA, 2015
- SMART‐COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community‐Acquired PneumoniaClinical Infectious Diseases, 2008
- Factors Predicting Mortality in Necrotizing Community-Acquired Pneumonia Caused by Staphylococcus aureus Containing Panton-Valentine LeukocidinClinical Infectious Diseases, 2007
- Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing StrategyClinical Infectious Diseases, 2007
- Development and Validation of a Clinical Prediction Rule for Severe Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2006